| 000 | 01561 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518083958.0 | ||
| 264 | 0 | _c20210617 | |
| 008 | 202106s 0 0 eng d | ||
| 022 | _a1873-4995 | ||
| 024 | 7 |
_a10.1016/j.jconrel.2020.02.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Yashi | |
| 245 | 0 | 0 |
_aA dual receptors-targeting and size-switchable "cluster bomb" co-loading chemotherapeutic and transient receptor potential ankyrin 1 (TRPA-1) inhibitor for treatment of triple negative breast cancer. _h[electronic resource] |
| 260 |
_bJournal of controlled release : official journal of the Controlled Release Society _c05 2020 |
||
| 300 |
_a71-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnkyrins |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDoxorubicin |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMicelles |
| 650 | 0 | 4 |
_aTRPA1 Cation Channel _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTriple Negative Breast Neoplasms _xdrug therapy |
| 700 | 1 | _aYin, Sheng | |
| 700 | 1 | _aMei, Lin | |
| 700 | 1 | _aYang, Yiliang | |
| 700 | 1 | _aXu, Shanshan | |
| 700 | 1 | _aHe, Xuan | |
| 700 | 1 | _aWang, Mou | |
| 700 | 1 | _aLi, Man | |
| 700 | 1 | _aZhang, Zhirong | |
| 700 | 1 | _aHe, Qin | |
| 773 | 0 |
_tJournal of controlled release : official journal of the Controlled Release Society _gvol. 321 _gp. 71-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jconrel.2020.02.010 _zAvailable from publisher's website |
| 999 |
_c30612069 _d30612069 |
||